Trials / Completed
CompletedNCT05761574
A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain
A Full-Factorial, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose Efficacy and Safety Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen, and Naproxen Sodium in Postoperative Dental Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 447 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI) · Industry
- Sex
- All
- Age
- 16 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate how well a fixed combination of acetaminophen/naproxen sodium relieves postoperative dental pain compared with acetaminophen, naproxen sodium and placebo.
Detailed description
This is a randomized, double-blind, placebo-controlled, single-dose full-factorial study to evaluate the analgesic efficacy and safety of a fixed combination of acetaminophen and naproxen sodium, compared with acetaminophen or naproxen sodium alone, and placebo following surgical extraction of three or four third molars.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetaminophen/Naproxen Sodium Fixed Combination | Fixed combination of Acetaminophen/Naproxen Sodium will be administered orally. |
| DRUG | Naproxen Sodium | Naproxen Sodium will be administered orally. |
| DRUG | Acetaminophen | Acetaminophen will be administered orally. |
| DRUG | Placebo | Placebo will be administered orally. |
Timeline
- Start date
- 2023-05-22
- Primary completion
- 2024-05-17
- Completion
- 2024-05-30
- First posted
- 2023-03-09
- Last updated
- 2025-07-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05761574. Inclusion in this directory is not an endorsement.